Cargando…
Interleukin-6 inhibitors in non-COVID-19 ARDS: analyzing the past to step into the post-COVID-19 era
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10039681/ https://www.ncbi.nlm.nih.gov/pubmed/36966340 http://dx.doi.org/10.1186/s13054-023-04394-w |
_version_ | 1784912321386119168 |
---|---|
author | Gandini, Lucia Fior, Gabriele Schibler, Andreas Obonyo, Nchafatso G. Li Bassi, Gianluigi Suen, Jacky Y. Fraser, John F. |
author_facet | Gandini, Lucia Fior, Gabriele Schibler, Andreas Obonyo, Nchafatso G. Li Bassi, Gianluigi Suen, Jacky Y. Fraser, John F. |
author_sort | Gandini, Lucia |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-10039681 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-100396812023-03-27 Interleukin-6 inhibitors in non-COVID-19 ARDS: analyzing the past to step into the post-COVID-19 era Gandini, Lucia Fior, Gabriele Schibler, Andreas Obonyo, Nchafatso G. Li Bassi, Gianluigi Suen, Jacky Y. Fraser, John F. Crit Care Comment BioMed Central 2023-03-25 /pmc/articles/PMC10039681/ /pubmed/36966340 http://dx.doi.org/10.1186/s13054-023-04394-w Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Comment Gandini, Lucia Fior, Gabriele Schibler, Andreas Obonyo, Nchafatso G. Li Bassi, Gianluigi Suen, Jacky Y. Fraser, John F. Interleukin-6 inhibitors in non-COVID-19 ARDS: analyzing the past to step into the post-COVID-19 era |
title | Interleukin-6 inhibitors in non-COVID-19 ARDS: analyzing the past to step into the post-COVID-19 era |
title_full | Interleukin-6 inhibitors in non-COVID-19 ARDS: analyzing the past to step into the post-COVID-19 era |
title_fullStr | Interleukin-6 inhibitors in non-COVID-19 ARDS: analyzing the past to step into the post-COVID-19 era |
title_full_unstemmed | Interleukin-6 inhibitors in non-COVID-19 ARDS: analyzing the past to step into the post-COVID-19 era |
title_short | Interleukin-6 inhibitors in non-COVID-19 ARDS: analyzing the past to step into the post-COVID-19 era |
title_sort | interleukin-6 inhibitors in non-covid-19 ards: analyzing the past to step into the post-covid-19 era |
topic | Comment |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10039681/ https://www.ncbi.nlm.nih.gov/pubmed/36966340 http://dx.doi.org/10.1186/s13054-023-04394-w |
work_keys_str_mv | AT gandinilucia interleukin6inhibitorsinnoncovid19ardsanalyzingthepasttostepintothepostcovid19era AT fiorgabriele interleukin6inhibitorsinnoncovid19ardsanalyzingthepasttostepintothepostcovid19era AT schiblerandreas interleukin6inhibitorsinnoncovid19ardsanalyzingthepasttostepintothepostcovid19era AT obonyonchafatsog interleukin6inhibitorsinnoncovid19ardsanalyzingthepasttostepintothepostcovid19era AT libassigianluigi interleukin6inhibitorsinnoncovid19ardsanalyzingthepasttostepintothepostcovid19era AT suenjackyy interleukin6inhibitorsinnoncovid19ardsanalyzingthepasttostepintothepostcovid19era AT fraserjohnf interleukin6inhibitorsinnoncovid19ardsanalyzingthepasttostepintothepostcovid19era |